Literature DB >> 15504744

Phosphorylation of NG2 proteoglycan by protein kinase C-alpha regulates polarized membrane distribution and cell motility.

Irwan T Makagiansar1, Scott Williams, Kimberlee Dahlin-Huppe, Jun-ichi Fukushi, Tomas Mustelin, William B Stallcup.   

Abstract

Protein kinase C (PKC)-alpha phosphorylation of recombinant NG2 cytoplasmic domain and phorbol ester-induced PKC-dependent phosphorylation of full-length NG2 expressed in U251 cells are both blocked by mutation of Thr(2256), identifying this residue as a primary phosphorylation site. In untreated U251/NG2 cells, NG2 is present along with ezrin and alpha(3)beta(1) integrin in apical cell surface protrusions. Phorbol ester treatment causes redistribution of all three components to lamellipodia, accompanied by increased cell motility. U251 cells expressing NG2 with a valine substitution at position 2256 are resistant to phorbol ester treatment: NG2 remains in membrane protrusions and cell motility is unchanged. In contrast, NG2 with a glutamic acid substitution at position 2256 redistributes to lamellipodia even without phorbol ester treatment, rendering transfected U251 cells spontaneously motile. PKC-alpha-mediated NG2 phosphorylation at Thr(2256) is therefore a key step for initiating cell polarization and motility.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504744     DOI: 10.1074/jbc.M411045200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  Roles of NG2 glial cells in diseases of the central nervous system.

Authors:  Jian-Ping Xu; Jie Zhao; Shao Li
Journal:  Neurosci Bull       Date:  2011-12       Impact factor: 5.203

Review 2.  NG2-expressing cells in the nervous system: role of the proteoglycan in migration and glial-neuron interaction.

Authors:  Khalad Karram; Nivedita Chatterjee; Jacqueline Trotter
Journal:  J Anat       Date:  2005-12       Impact factor: 2.610

3.  Immunohistochemical study of NG2 chondroitin sulfate proteoglycan expression in the small and large intestines.

Authors:  Nobuo Terada; Nobuhiko Ohno; Shinichi Murata; Ryohei Katoh; William B Stallcup; Shinichi Ohno
Journal:  Histochem Cell Biol       Date:  2006-04-20       Impact factor: 4.304

4.  Identification of subtilase cytotoxin (SubAB) receptors whose signaling, in association with SubAB-induced BiP cleavage, is responsible for apoptosis in HeLa cells.

Authors:  Kinnosuke Yahiro; Mamoru Satoh; Naoko Morinaga; Hiroyasu Tsutsuki; Kohei Ogura; Sayaka Nagasawa; Fumio Nomura; Joel Moss; Masatoshi Noda
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

5.  NG2 proteoglycan expression in mouse skin: altered postnatal skin development in the NG2 null mouse.

Authors:  Kuniko Kadoya; Jun-Ichi Fukushi; Yoshihiro Matsumoto; Yu Yamaguchi; William B Stallcup
Journal:  J Histochem Cytochem       Date:  2007-11-26       Impact factor: 2.479

6.  The NG2 proteoglycan promotes oligodendrocyte progenitor proliferation and developmental myelination.

Authors:  K Kucharova; W B Stallcup
Journal:  Neuroscience       Date:  2009-12-16       Impact factor: 3.590

7.  Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse.

Authors:  Feng-Ju Huang; Weon-Kyoo You; Paolo Bonaldo; Thomas N Seyfried; Elena B Pasquale; William B Stallcup
Journal:  Dev Biol       Date:  2010-06-27       Impact factor: 3.582

Review 8.  Transduction of extracellular cues into cell polarity: the role of the transmembrane proteoglycan NG2.

Authors:  Fabien Binamé
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

9.  Adventitial pericyte progenitor/mesenchymal stem cells participate in the restenotic response to arterial injury.

Authors:  Ulrich Tigges; Masanobu Komatsu; William B Stallcup
Journal:  J Vasc Res       Date:  2012-12-18       Impact factor: 1.934

Review 10.  Proteoglycans and their roles in brain cancer.

Authors:  Anna Wade; Aaron E Robinson; Jane R Engler; Claudia Petritsch; C David James; Joanna J Phillips
Journal:  FEBS J       Date:  2013-02-06       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.